"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

Record History

See every version on ClinicalTrials.gov ↗

1. Minor Jul 9, 2026 Enrollment target: 240 to 205v6 Show 8 more changesShow less

   • Primary completion date: Dec 1, 2005
   • Study completion date: Feb 2006 to Dec 1, 2005
   • Start date: Apr 2003 to Apr 1, 2003
   • Interventions: tolvaptan (Drug) to placebo matching tolvaptan (Drug), tolvaptan (Drug)
   • Eligibility criteria expanded, about 10 words
   • Study sites revised (23)
   • Study arms: 0 to 2
   • Study description expanded, about 1 word
2. Jan 24, 2007 Re-verified, no change to tracked fieldsv5
3. Notable Apr 14, 2006 Primary endpoints revised (2)

   • Trial status: Active, Not Recruiting to Completed
   • Secondary endpoints revised (17)

   v4
4. Minor Mar 2, 2006 Trial status: Recruiting to Active, Not Recruiting

   • Study sites revised (23)

   v3
5. Notable Sep 13, 2005 Trial status: Not Yet Recruiting to Recruitingv2 Show 8 more changesShow less

   • Enrollment target: 240
   • Study sites: 9 to 23
   • Study completion date: Feb 2006
   • Start date: Apr 2003
   • Eligibility criteria expanded, about 336 words
   • Study description expanded, about 336 words
   • Collaborators expanded, about 4 words
   • Study title expanded, about 4 words
6. Jun 23, 2005 Study First Submitted

• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.